Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JS Smolen
SAT0142 Predictors of Inadequate Response and Rapid Radiographic Progression in Patients With Early Rheumatoid Arthritis Receiving Methotrexate: A Post Hoc Analysis of 2 Randomized, Controlled Trials of Adalimumab
P121/O21 MiR-146A an Important Key Player in Bone Metabolism
Interphase Fluorescence in Situ Hybridization Analysis of Fibroblast-Like Synoviocytes of Patients With Rheumatoid Arthritis and Osteoarthritis
Arthritis Research & Therapy
Related publications
Predictors of Pneumonia on Routine Chest Radiographs in Patients With COPD: A Post Hoc Analysis of Two 1-Year Randomized Controlled Trials
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone
RMD Open
Rheumatology
Allergy
Immunology
Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis
New England Journal of Medicine
Medicine
Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Effect of Ertugliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus: A Post Hoc Pooled Analysis of Randomized Controlled Trials
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Efficacy and Safety of Tofacitinib in Japanese Patients With Rheumatoid Arthritis by Background Methotrexate Dose: A Post-Hoc Analysis of Clinical Trial Data
Modern Rheumatology
Medicine
Rheumatology
Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Adalimumab in the Treatment of Early Rheumatoid Arthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
